Oliver Stoeltzing

5.6k total citations
73 papers, 4.6k citations indexed

About

Oliver Stoeltzing is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Oliver Stoeltzing has authored 73 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 29 papers in Cancer Research and 26 papers in Oncology. Recurrent topics in Oliver Stoeltzing's work include Angiogenesis and VEGF in Cancer (35 papers), Cancer, Hypoxia, and Metabolism (23 papers) and Heat shock proteins research (11 papers). Oliver Stoeltzing is often cited by papers focused on Angiogenesis and VEGF in Cancer (35 papers), Cancer, Hypoxia, and Metabolism (23 papers) and Heat shock proteins research (11 papers). Oliver Stoeltzing collaborates with scholars based in United States, Germany and Switzerland. Oliver Stoeltzing's co-authors include Lee M. Ellis, Fan Fan, Wenbiao Liu, Niels Reinmuth, Alexander A. Parikh, Corazon D. Bucana, Marya F. McCarty, Hans J. Schlitt, Sven A. Lang and Edward K. Geissler and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Oliver Stoeltzing

72 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oliver Stoeltzing United States	43	3.0k	1.6k	1.4k	538	402	73	4.6k
Adrian M. Jubb United Kingdom	32	2.5k 0.8×	1.6k 1.1×	1.0k 0.7×	630 1.2×	173 0.4×	50	4.0k
Yasuhiro Hida Japan	42	3.0k 1.0×	1.7k 1.1×	1.8k 1.3×	815 1.5×	509 1.3×	162	5.5k
Laura K. Shawver United States	26	3.4k 1.1×	2.0k 1.3×	1.2k 0.9×	562 1.0×	158 0.4×	47	5.1k
Josep Baulida Spain	24	3.9k 1.3×	2.6k 1.7×	932 0.7×	410 0.8×	356 0.9×	33	5.6k
Andrew B. Nixon United States	33	3.3k 1.1×	2.2k 1.4×	685 0.5×	711 1.3×	320 0.8×	168	5.6k
Xiulan Zhao China	44	3.8k 1.3×	2.0k 1.3×	2.3k 1.7×	718 1.3×	237 0.6×	135	5.5k
Keiji Shimada Japan	42	2.5k 0.8×	1.4k 0.9×	1.0k 0.7×	694 1.3×	876 2.2×	161	4.9k
Mariona Graupera Spain	35	2.4k 0.8×	978 0.6×	546 0.4×	494 0.9×	713 1.8×	59	4.6k
Andrei V. Bakin United States	36	4.8k 1.6×	1.8k 1.1×	914 0.7×	423 0.8×	224 0.6×	60	6.0k
Jung Young Lee South Korea	48	4.7k 1.6×	1.5k 0.9×	1.4k 1.0×	494 0.9×	351 0.9×	119	5.9k

Countries citing papers authored by Oliver Stoeltzing

Since Specialization

Citations

This map shows the geographic impact of Oliver Stoeltzing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Stoeltzing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Stoeltzing more than expected).

Fields of papers citing papers by Oliver Stoeltzing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Stoeltzing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Stoeltzing. The network helps show where Oliver Stoeltzing may publish in the future.

Co-authorship network of co-authors of Oliver Stoeltzing

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Stoeltzing. A scholar is included among the top collaborators of Oliver Stoeltzing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Stoeltzing. Oliver Stoeltzing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moser, Christian, Sven A. Lang, Christina Hackl, et al.. (2012). Oncogenic MST1R activity in pancreatic and gastric cancer represents a valid target of HSP90 inhibitors.. PubMed. 32(2). 427–37. 10 indexed citations

Moser, Christian, Claus Hellerbrand, Maria E. Mycielska, et al.. (2011). Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer. Molecular Cancer Therapeutics. 10(11). 2157–2167. 117 indexed citations

Lang, Sven A., Christina Hackl, Christian Moser, et al.. (2010). Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1803(4). 435–442. 42 indexed citations

Mori, Akira, Christian Moser, Sven A. Lang, et al.. (2009). Up-Regulation of Krüppel-Like Factor 5 in Pancreatic Cancer Is Promoted by Interleukin-1β Signaling and Hypoxia-Inducible Factor-1α. Molecular Cancer Research. 7(8). 1390–1398. 61 indexed citations

Hackl, Christina, Akira Mori, Christian Moser, et al.. (2009). Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models. Surgery. 147(5). 704–712. 13 indexed citations

Stoeltzing, Oliver, Martin Loss, Elisabeth Huber, et al.. (2009). Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor. Langenbeck s Archives of Surgery. 395(2). 185–192. 57 indexed citations

Lang, Sven Arke, Akira Mori, Christina Hackl, et al.. (2008). Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes. Molecular Cancer Therapeutics. 7(11). 3509–3518. 46 indexed citations

Lang, Sven A., Christian Moser, Claus Hellerbrand, et al.. (2008). Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice #. Hepatology. 49(2). 523–532. 49 indexed citations

Moser, Christian, Sven A. Lang, Karen Lundgren, et al.. (2008). Targeting Hsp90 using EC154, a novel synthetic Hsp90 inhibitor, impairs multiple oncogenic signaling pathways in human gastric and pancreatic cancer cells and reduces tumor growth in vivo. Cancer Research. 68. 1181–1181. 1 indexed citations

10.

Lang, Sven Arke, et al.. (2008). Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental model. Langenbeck s Archives of Surgery. 393(3). 333–341. 8 indexed citations

11.

Stoeltzing, Oliver, Wenbiao Liu, Fan Fan, et al.. (2007). Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system. Cancer Letters. 258(2). 291–300. 25 indexed citations

12.

Stoeltzing, Oliver, Funda Meric‐Bernstam, & Lee M. Ellis. (2006). Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpected. Cancer Cell. 10(2). 89–91. 45 indexed citations

13.

Wey, Jane, Michael J. Gray, Fei Fan, et al.. (2005). Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. British Journal of Cancer. 93(2). 233–241. 103 indexed citations

14.

Fan, Fan, Oliver Stoeltzing, Wenbiao Liu, et al.. (2004). Interleukin-1β Regulates Angiopoietin-1 Expression in Human Endothelial Cells. Cancer Research. 64(9). 3186–3190. 57 indexed citations

15.

Parikh, Alexander A., Fan Fan, Syed A. Ahmad, et al.. (2004). Neuropilin-1 in Human Colon Cancer. American Journal Of Pathology. 164(6). 2139–2151. 143 indexed citations

16.

Stoeltzing, Oliver, Marya F. McCarty, Jane Wey, et al.. (2004). Role of Hypoxia-Inducible Factor 1 in Gastric Cancer Cell Growth, Angiogenesis, and Vessel Maturation. JNCI Journal of the National Cancer Institute. 96(12). 946–956. 202 indexed citations

17.

Wey, Jane, Oliver Stoeltzing, & Lee M. Ellis. (2004). Vascular endothelial growth factor receptors: expression and function in solid tumors.. PubMed. 2(1). 37–45. 42 indexed citations

18.

Stoeltzing, Oliver, Wenbiao Liu, Niels Reinmuth, et al.. (2003). Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer. American Journal Of Pathology. 163(3). 1001–1011. 134 indexed citations

19.

Liu, Wenbiao, Niels Reinmuth, Oliver Stoeltzing, et al.. (2003). Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways.. PubMed. 63(13). 3632–6. 118 indexed citations

20.

Schneider, Paul M., Oliver Stoeltzing, John T. Manning, et al.. (2000). Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer. British Journal of Cancer. 83(4). 473–479. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact